Barry Moze
EVP, Corporate Dev't., Horizon Therapeutics Public Ltd Co.
Companies
- Horizon Therapeutics Public Ltd CoEVP, Corporate Dev't. Sep 22, 2014 to Jan 6, 20221
- Horizon Therapeutics Public Ltd CoChief operating officer Mar 24, 2016 to Sep 13, 20162
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Horizon Therapeutics Public Ltd Co138,174 shares3Jan 5, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 5, 2022Shares withheld for tax 49,841 shares at $101.84 of Horizon Therapeutics Public Ltd Co3
- Jan 5, 2022Granted 47,375 shares of Horizon Therapeutics Public Ltd Co3
- Jan 5, 2022Exercised options 64,959 shares of Horizon Therapeutics Public Ltd Co3
- Nov 4, 2021Sold 5,724 shares at $115.45 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Sold 6,763 shares at $114.43 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Sold 17,867 shares at $113.56 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Sold 6,151 shares at $112.60 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Sold 15,856 shares at $111.75 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Sold 23,382 shares at $110.17 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Exercised options 72,300 shares at $14.48 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Exercised options 443 shares at $11.81 of Horizon Therapeutics Public Ltd Co4
- Nov 4, 2021Exercised options 3,000 shares at $22.14 of Horizon Therapeutics Public Ltd Co4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Nov 5, 2021